Endra Life Sciences Inc (NDRA) Stock Price, Quote & News

Company Profile

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 734 335 0468

Website: endrainc.com

Address:

3600 Green Court, Suite 350, Ann Arbor, United States

d_risk Nov. 14 at 10:51 PM

$NDRA - ENDRA Life Sciences Inc. - 10Q - Updated Risk Factors NDRA flags new risks from competing digital assets, plans to invest heavily in volatile cryptocurrencies, highlights lack of investment company regulation, and warns of major threats from blockchain disruptions and attacks. #DigitalAssets #Volatility #BlockchainSecurity #RegulatoryRisk #CryptocurrencyInvestment 🟢 Added 🟠 Removed https://d-risk.ai/NDRA/10-Q/2025-11-14

0 · Reply

NewsAndFilings Nov. 14 at 12:47 PM

Yesterday's Recap: $BMTM Time Business News Article $PETV Digital Landia Publishes Technical Whitepaper $NDRA Staking of HYPE Digital Asset Holdings $BLGO Q3 Financials $SNYR Q3 Financials

0 · Reply

yellowjacker Nov. 14 at 12:28 AM

$NDRA I am not a block chain/ tech guy. So by intering into this agreement not only does it secure the infomation when using their device, but also will give them more exposure in studing the info and giving them coverage or exposure to the medical field. It also gives them 14 million in funding to get the final product out. If I am right with the float under 1 million shares, it could also put out the exposure to a buyer who would like to buy them out.. Is that a fair assessment?

0 · Reply

MsGrumpy Nov. 13 at 5:36 PM

$NDRA ENDRA Life Sciences Inc. a redefining the intersection of healthcare technology and decentralized finance https://thestreetreports.com/endra-life-sciences-inc-nasdaq-ndra-digital-asset-tokenization-to-drive-long-term-shareholder-value/

0 · Reply

MsGrumpy Nov. 13 at 3:48 PM

$NDRA ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings https://www.businesswire.com/news/home/20251113934707/en/ENDRA-Life-Sciences-Commences-Staking-of-HYPE-Digital-Asset-Holdings-Reinforcing-Long-Term-Strategy-with-Anchorage-Digital-and-ARCA

0 · Reply

NewsAndFilings Nov. 13 at 3:37 PM

$NDRA ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA https://www.businesswire.com/news/home/20251113934707/en/ENDRA-Life-Sciences-Commences-Staking-of-HYPE-Digital-Asset-Holdings-Reinforcing-Long-Term-Strategy-with-Anchorage-Digital-and-ARCA

0 · Reply

Giants67 Nov. 13 at 3:36 PM

0 · Reply

THUNDERMAN01 Nov. 13 at 1:08 PM

$NDRA ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

0 · Reply

makedatbread88 Nov. 12 at 6:47 PM

$NDRA 682k low float keep an eye Crypto news few weeks ago Maybe runs off of $CYPH

0 · Reply

DrewSerick Nov. 10 at 2:40 AM

$NDRA Looks good for a bounce

0 · Reply

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

Oct 23, 2025, 8:00 AM EDT - 22 days ago

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Oct 13, 2025, 8:00 AM EDT - 4 weeks ago

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

Aug 14, 2025, 4:05 PM EDT - 3 months ago

ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

Jun 16, 2025, 8:00 AM EDT - 5 months ago

ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

May 15, 2025, 4:05 PM EDT - 6 months ago

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

Mar 31, 2025, 8:05 AM EDT - 8 months ago

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

Mar 31, 2025, 8:00 AM EDT - 8 months ago

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

Nov 22, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nov 15, 2024, 9:24 AM EST - 1 year ago

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024

Nov 6, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

Oct 22, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany

Aug 30, 2024, 8:54 AM EDT - 1 year ago

Data I/O And 2 Other Stocks Under $5 Executives Are Buying

DAIO

Aug 28, 2024, 4:17 PM EDT - 1 year ago

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

Aug 22, 2024, 5:54 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript

Aug 22, 2024, 4:14 PM EDT - 1 year ago

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 16, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Announces Reverse Stock Split

Aug 13, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024

Aug 13, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Announces Leadership Changes

Aug 7, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14

Jun 4, 2024, 9:21 AM EDT - 1 year ago

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering

Jun 4, 2024, 9:06 AM EDT - 1 year ago

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit

May 20, 2024, 8:00 AM EDT - 1 year ago

ENDRA Provides Update Following In-person Meeting with FDA

May 14, 2024, 8:30 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

May 7, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

May 2, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents

Mar 28, 2024, 9:10 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 21, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

Feb 27, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Installs First TAEUS System in the UK

Feb 21, 2024, 8:00 AM EST - 1 year ago

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

Feb 14, 2024, 8:30 AM EST - 1 year ago

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

Nov 29, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

Nov 27, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences to Participate in The Benchmark Company's 12th Annual Discovery One-on-One Investor Conference

Nov 14, 2023, 10:14 PM EST - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 4:05 PM EST - 2 years ago

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents

Nov 7, 2023, 4:05 PM EST - 2 years ago

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

Nov 6, 2023, 8:00 AM EST - 2 years ago

ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD's The Liver Meeting® 2023

Sep 7, 2023, 8:00 AM EDT - 2 years ago

Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023

Aug 30, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA

Aug 23, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents

Aug 14, 2023, 9:44 PM EDT - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update

Aug 14, 2023, 1:30 PM EDT - 2 years ago

ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA

Aug 1, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

Jul 6, 2023, 4:45 PM EDT - 2 years ago

ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023

Jun 7, 2023, 8:00 AM EDT - 2 years ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology to be Presented at EASL International Liver Congress 2023

d_risk Nov. 14 at 10:51 PM

0 · Reply

NewsAndFilings Nov. 14 at 12:47 PM

Yesterday's Recap: $BMTM Time Business News Article $PETV Digital Landia Publishes Technical Whitepaper $NDRA Staking of HYPE Digital Asset Holdings $BLGO Q3 Financials $SNYR Q3 Financials

0 · Reply

yellowjacker Nov. 14 at 12:28 AM

0 · Reply

MsGrumpy Nov. 13 at 5:36 PM

0 · Reply

MsGrumpy Nov. 13 at 3:48 PM

0 · Reply

NewsAndFilings Nov. 13 at 3:37 PM

0 · Reply

Giants67 Nov. 13 at 3:36 PM

0 · Reply

THUNDERMAN01 Nov. 13 at 1:08 PM

$NDRA ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

0 · Reply

makedatbread88 Nov. 12 at 6:47 PM

$NDRA 682k low float keep an eye Crypto news few weeks ago Maybe runs off of $CYPH

0 · Reply

DrewSerick Nov. 10 at 2:40 AM

$NDRA Looks good for a bounce

0 · Reply

Skidknee Nov. 6 at 7:59 PM

$NDRA eyes here

0 · Reply

PiratesKingLuffy Nov. 5 at 5:31 AM

Looking for the next parabolic runner?? Make sure to keep eyes on ticker VEEE .💎 VEEE catching serious attention after that $4.X.25M property sale. Tiny float✅ Clean balance sheet✅ Not many tickers trading under $3.X with real assets and no debt VEE is one💎 The setup here is one of a kind, this has the look to go massive. Make sure not to miss out tomorrow bulls! $DRMA $COOT $NDRA $BDRX ..4

0 · Reply

JL_TradeZ Nov. 3 at 2:30 AM

4-Month Special Play Recap 🔥 Crazy stretch the last few months. From July to October we caught over 30 special plays with some massive runs $NBY +566%, $HUDI +366%, $AIHS +310%, $AQMS +426%, $NDRA +222% and plenty more to name a few. The goal’s always been to stay consistent, track momentum early, and find clean setups before the crowd. Going to keep doing my best to spot and track more solid special plays for the team as we head into November 💪

1 · Reply

ReformedTraders Nov. 1 at 11:40 PM

$LBGJ Top runner for Monday! $VSEE $NDRA $AZTR

0 · Reply

isaacwilliams33 Oct. 30 at 12:04 AM

$NDRA

0 · Reply

ZacksResearch Oct. 24 at 2:00 PM

$NDRA is up 4% in premarket trading 🚀 💰 NDRA closed its $4.9M PIPE financing, led by institutional and crypto investors, with potential for an additional $9.5M via warrants. 🌐 The company also launched its Digital Asset Treasury (DAT) strategy, acquiring ~78.9K HYPE tokens (~$3M) — a top Arca DeFi holding. ⚡ CEO Alexander Tokman calls it a “foundational step” in deploying capital into innovative, yield-generating digital ecosystems — blending biotech innovation with Web3 finance. Check out the latest for the stock here. https://www.zacks.com/stock/quote/NDRA?q=NDRA&cid=sm-stocktwits-0-quote_overview-oc-17450&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_17450

0 · Reply

drwaz Oct. 24 at 10:53 AM

$NDRA 👀

0 · Reply

_www_larval_com_ Oct. 23 at 7:07 PM

$NDRA has reverted 4% higher to -3% (~947Kv) moments ago, follow for more volatility.

0 · Reply

VMAESA Oct. 23 at 2:51 PM

Stop✋ looking at those pointless “alerts” when your clueless furu’s cant show you results like these👇 Follow & use the link in bio to join the BEST community on this planet🥳 $AREB $NDRA $GNPX $VTYX $SLMT

0 · Reply

dndodd Oct. 23 at 1:47 PM

$NDRA getting into crypto tokens called HYPE. unbelievable.

0 · Reply

VMAESA Oct. 23 at 12:41 PM

$NITO $NDRA Quick morning shorts

0 · Reply

tradeXLNC Oct. 23 at 12:30 PM

#xlnc #scanner ☀️Good morning folks, some runners that hit our scanner today in the premarket session – $NDRA $SCNX $NITO

1 · Reply

Market Cap	4.71M
Revenue (ttm)	0.00
Net Income (ttm)	-11.51M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	25,600
Avg Vol	343,724
Day's Range	N/A - N/A
Shares Out	753,000.00
Stochastic %K	85%
Beta	-0.09
Analysts	Sell
Price Target	$38.00